139 related articles for article (PubMed ID: 32072500)
1. Molecular Regulation of Notch Signaling by Gremlin.
Marquez-Exposito L; Cantero-Navarro E; R Rodrigues-Diez R; Orejudo M; Tejera-Muñoz A; Tejedor L; Rayego-Mateos S; Rández-Carbayo J; Santos-Sanchez L; Mezzano S; Lavoz C; Ruiz-Ortega M
Adv Exp Med Biol; 2020; 1227():81-94. PubMed ID: 32072500
[TBL] [Abstract][Full Text] [Related]
2. Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway.
Lavoz C; Alique M; Rodrigues-Diez R; Pato J; Keri G; Mezzano S; Egido J; Ruiz-Ortega M
J Pathol; 2015 Aug; 236(4):407-20. PubMed ID: 25810250
[TBL] [Abstract][Full Text] [Related]
3. Gremlin and renal diseases: ready to jump the fence to clinical utility?
Mezzano S; Droguett A; Lavoz C; Krall P; Egido J; Ruiz-Ortega M
Nephrol Dial Transplant; 2018 May; 33(5):735-741. PubMed ID: 28992340
[TBL] [Abstract][Full Text] [Related]
4. Gremlin activates the Notch pathway linked to renal inflammation.
Lavoz C; Poveda J; Marquez-Exposito L; Rayego-Mateos S; Rodrigues-Diez RR; Ortiz A; Egido J; Mezzano S; Ruiz-Ortega M
Clin Sci (Lond); 2018 Jun; 132(11):1097-1115. PubMed ID: 29720422
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Gremlin-VEGFR2 axis - a promising strategy for multiple diseases?
Erdmann R; Ozden C; Weidmann J; Schultze A
J Pathol; 2015 Aug; 236(4):403-6. PubMed ID: 25875212
[TBL] [Abstract][Full Text] [Related]
6. Co-regulation of Gremlin and Notch signalling in diabetic nephropathy.
Walsh DW; Roxburgh SA; McGettigan P; Berthier CC; Higgins DG; Kretzler M; Cohen CD; Mezzano S; Brazil DP; Martin F
Biochim Biophys Acta; 2008 Jan; 1782(1):10-21. PubMed ID: 17980714
[TBL] [Abstract][Full Text] [Related]
7. Gremlin is a downstream profibrotic mediator of transforming growth factor-beta in cultured renal cells.
Rodrigues-Diez R; Lavoz C; Carvajal G; Rayego-Mateos S; Rodrigues Diez RR; Ortiz A; Egido J; Mezzano S; Ruiz-Ortega M
Nephron Exp Nephrol; 2012; 122(1-2):62-74. PubMed ID: 23548835
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid Hormone-Related Protein Interacts With the Transforming Growth Factor-β/Bone Morphogenetic Protein-2/Gremlin Signaling Pathway to Regulate Proinflammatory and Profibrotic Mediators in Pancreatic Acinar and Stellate Cells.
Bhatia V; Cao Y; Ko TC; Falzon M
Pancreas; 2016; 45(5):659-70. PubMed ID: 26495794
[TBL] [Abstract][Full Text] [Related]
9. Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2.
Mitola S; Ravelli C; Moroni E; Salvi V; Leali D; Ballmer-Hofer K; Zammataro L; Presta M
Blood; 2010 Nov; 116(18):3677-80. PubMed ID: 20660291
[TBL] [Abstract][Full Text] [Related]
10. Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist.
Grillo E; Ravelli C; Corsini M; Ballmer-Hofer K; Zammataro L; Oreste P; Zoppetti G; Tobia C; Ronca R; Presta M; Mitola S
Oncotarget; 2016 Jun; 7(23):35353-68. PubMed ID: 27174917
[TBL] [Abstract][Full Text] [Related]
11. Gremlin-mediated decrease in bone morphogenetic protein signaling promotes pulmonary fibrosis.
Myllärniemi M; Lindholm P; Ryynänen MJ; Kliment CR; Salmenkivi K; Keski-Oja J; Kinnula VL; Oury TD; Koli K
Am J Respir Crit Care Med; 2008 Feb; 177(3):321-9. PubMed ID: 17975199
[TBL] [Abstract][Full Text] [Related]
12. Gremlin Regulates Tubular Epithelial to Mesenchymal Transition via VEGFR2: Potential Role in Renal Fibrosis.
Marquez-Exposito L; Lavoz C; Rodrigues-Diez RR; Rayego-Mateos S; Orejudo M; Cantero-Navarro E; Ortiz A; Egido J; Selgas R; Mezzano S; Ruiz-Ortega M
Front Pharmacol; 2018; 9():1195. PubMed ID: 30386246
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.
Chiodelli P; Mitola S; Ravelli C; Oreste P; Rusnati M; Presta M
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e116-27. PubMed ID: 21921258
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein 7 suppresses the progression of hepatic fibrosis and regulates the expression of gremlin and transforming growth factor β1.
Yang T; Chen SL; Lu XJ; Shen CY; Liu Y; Chen YP
Mol Med Rep; 2012 Jul; 6(1):246-52. PubMed ID: 22552821
[TBL] [Abstract][Full Text] [Related]
15. Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin.
Corsini M; Moroni E; Ravelli C; Andrés G; Grillo E; Ali IH; Brazil DP; Presta M; Mitola S
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):136-45. PubMed ID: 24233491
[TBL] [Abstract][Full Text] [Related]
16. Expression of gremlin, a bone morphogenetic protein antagonist, in glomerular crescents of pauci-immune glomerulonephritis.
Mezzano S; Droguett A; Burgos ME; Aros C; Ardiles L; Flores C; Carpio D; Carvajal G; Ruiz-Ortega M; Egido J
Nephrol Dial Transplant; 2007 Jul; 22(7):1882-90. PubMed ID: 17403698
[TBL] [Abstract][Full Text] [Related]
17. Gremlin promotes retinal pigmentation epithelial (RPE) cell proliferation, migration and VEGF production via activating VEGFR2-Akt-mTORC2 signaling.
Liu Y; Chen Z; Cheng H; Chen J; Qian J
Oncotarget; 2017 Jan; 8(1):979-987. PubMed ID: 27894090
[TBL] [Abstract][Full Text] [Related]
18. Gremlin Regulates Podocyte Apoptosis via Transforming Growth Factor-β (TGF-β) Pathway in Diabetic Nephropathy.
Wang XB; Zhu H; Song W; Su JH
Med Sci Monit; 2018 Jan; 24():183-189. PubMed ID: 29315280
[TBL] [Abstract][Full Text] [Related]
19. Gremlin inhibits UV-induced skin cell damages via activating VEGFR2-Nrf2 signaling.
Ji C; Huang JW; Xu QY; Zhang J; Lin MT; Tu Y; He L; Bi ZG; Cheng B
Oncotarget; 2016 Dec; 7(51):84748-84757. PubMed ID: 27713170
[TBL] [Abstract][Full Text] [Related]
20. The binding of the bone morphogenetic protein antagonist gremlin to kidney heparan sulfate: Such binding is not essential for BMP antagonism.
Tatsinkam AJ; Rune N; Smith J; Norman JT; Mulloy B; Rider CC
Int J Biochem Cell Biol; 2017 Feb; 83():39-46. PubMed ID: 27979781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]